Priya Kumthekar
Associate Program Director, Neuro-Oncology · McGaw Medical Center of Northwestern University
Credentials: · · ·
History
PresentNeuro-Oncology · McGaw Medical Center of Northwestern University
- Present
Brain Metastases Program · McGaw Medical Center of Northwestern University
2003–2007
Research
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 405 citations
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine · 2023 · 266 citations
Science Translational Medicine · 2021 · First of 37 authors · Corresponding · 265 citations
30 papers
21 papers · 1 as a fellow
20 papers
20 papers
15 papers
14 papers
11 papers
11 papers
Grants
- 2023–2028
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation
National Cancer Institute · R01
PI · $2.3M · Northwestern University
- 1997–2023
The Robert H. Lurie Comprehensive Cancer Center
National Cancer Institute · P30
Project lead · $490.9K · Northwestern University
Clinical trials
- 2022–2023
A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide
Principal investigator · Terminated
Biocept, Inc.
- 2022–2029
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
Principal investigator · Active not recruiting · Phase 1
Northwestern University
- 2017–2020
NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
Principal investigator · Completed · Early phase 1
Northwestern University
- 2016–2026
Principal investigator · Completed · Phase 2
Northwestern University